Federal contract award
75N98C25P00062
GEM-X UNIVERSAL 3' GENE EXPRESSION V4, 16 SAMPLES AND DUAL INDEX KIT TT SET A, 96 RXN
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INTITUTES OF HEALTH NIDCD |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $23.5K |
| Current contract value | $23.5K |
| Potential contract value / ceiling | $23.5K |
| Start date | May 12, 2025 |
| Current end date | May 11, 2026 |
| Potential end date | May 11, 2026 |
| Latest award activity | May 13, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 13, 2025 | 0 | $23.5K | GEM-X UNIVERSAL 3' GENE EXPRESSION V4, 16 SAMPLES AND DUAL INDEX KIT TT SET A, 96 RXN |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.